Kwality Pharmaceuticals Ltd
10 Aug 2026 12:00 AM
Kwality Pharmaceuticals to convene AGM,
Kwality Pharmaceuticals announced that the 43th Annual General Meeting(AGM) of the company will be held on 31 August 2026.
Kwality Pharmaceuticals Ltd
10 Aug 2026 12:00 AM
Kwality Pharmaceuticals consolidated net profit rises 114.75% in the June 2026 quarter,
Net profit of Kwality Pharmaceuticals rose 114.75% to Rs 25.62 crore in the quarter ended June 2026 as against Rs 11.93 crore during the previous quarter ended June 2025. Sales rose 45.63% to Rs 162.35 crore in the quarter ended June 2026 as against Rs 111.48 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales162.35111.48 46 OPM %25.2721.68 - PBDT38.9821.79 79 PBT33.9917.03 100 NP25.6211.93 115 Powered by Capital Market - Live News
Kwality Pharmaceuticals Ltd
04 Aug 2026 12:00 AM
Kwality Pharmaceuticals schedules board meeting,
Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 August 2026.
Kwality Pharmaceuticals Ltd
24 Jul 2026 12:00 AM
Kwality Pharmaceuticals receives CDSCO approval to manufacture Pembroluzimab for preclinical studies,
Kwality Pharmaceuticals has achieved a significant milestone in its biologics development journey after receiving permission from the Central Drugs Standard Control Organization (CDSCO) to manufacture pilot batches of Pembroluzimab for preclinical studies.The approval follows a comprehensive review of the product`s development data submitted by the Company`s R&D team. Based on the data evaluated, CDSCO has granted permission to proceed with pilot-scale manufacturing for the generation of preclinical batches, marking the product`s transition from the research and development stage to Pre-Clinical stage.
Kwality Pharmaceuticals Ltd
19 May 2026 12:00 AM
Kwality Pharmaceuticals consolidated net profit rises 74.60% in the March 2026 quarter,
Net profit of Kwality Pharmaceuticals rose 74.60% to Rs 25.30 crore in the quarter ended March 2026 as against Rs 14.49 crore during the previous quarter ended March 2025. Sales rose 35.81% to Rs 157.11 crore in the quarter ended March 2026 as against Rs 115.68 crore during the previous quarter ended March 2025.For the full year,net profit rose 69.01% to Rs 67.35 crore in the year ended March 2026 as against Rs 39.85 crore during the previous year ended March 2025. Sales rose 35.89% to Rs 503.08 crore in the year ended March 2026 as against Rs 370.20 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales157.11115.68 36 503.08370.20 36 OPM %24.6722.37 -23.5021.72 - PBDT36.9324.16 53 110.1372.43 52 PBT31.6719.07 66 90.3254.14 67 NP25.3014.49 75 67.3539.85 69 Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter
HSL Mobile App